Details About Generic Salt ::  Glipizid

Main Medicine Class:: Antidiabetic,Sulfonylurea   

Glucotrol Glucotrol XL
Class: Antidiabetic/Sulfonylurea


Drugs Class ::

 Action Decreases blood glucose by stimulating insulin release from pancreas and by increasing tissue sensitivity to insulin.

Indications for Drugs ::

 Indications Adjunct to diet to lower blood glucose in patients with non-insulin-dependent diabetes mellitus (type II) whose hyperglycemia cannot be controlled by diet alone.

Drug Dose ::


ADULTS: PO 5 mg/day 30 min before breakfast. Dose should be adjusted in 2.5 to 5 mg/day increments based on blood glucose response. Divided doses may be given (maximum single daily dose 15 mg; maximum total daily dose 40 mg). ELDERLY OR PATIENTS WITH LIVER DISEASE: PO 2.5 mg/day initially.

Contraindication ::

 Contraindications Hypersensitivity to sulfonylureas; diabetes complicated by ketoacidosis, with or without coma; sole therapy of insulin-dependent (type I) diabetes mellitus; diabetes when complicated by pregnancy.

Drug Precautions ::


Pregnancy: Category C. Insulin is recommended to maintain blood glucose levels during pregnancy. Prolonged severe neonatal hypoglycemia can occur if sulfonylureas are administered at time of delivery. Lactation: Undetermined. Children: Safety and efficacy not established. Elderly and debilitated patients: Elderly and debilitated patients are particularly susceptible to hypoglycemic action. Hypoglycemia may be difficult to recognize in elderly. Hepatic and renal impairment: Use drug with caution and monitor liver and renal function frequently.


Drug Side Effects ::

 Adverse Reactions

CV: May have increased risk of cardiovascular mortality when compared with patients treated with diet alone. CNS: Dizziness; vertigo. DERM: Allergic skin reactions; eczema; pruritus; erythema; urticaria; morbilliform or maculopapular eruptions; lichenoid reactions; photosensitivity. EENT: Tinnitus. GI: GI disturbances (eg, nausea, epigastric fullness, heartburn); diarrhea. GU: Mild diuresis; elevated BUN and creatinine. HEPA: Cholestatic jaundice; elevated liver function test results. HEMA: Leukopenia; thrombocytopenia; aplastic anemia; agranulocytosis; hemolytic anemia; pancytopenia; hepatic porphyria. META: Hypoglycemia. OTHER: Disulfiram-like reaction; weakness; paresthesia; fatigue; malaise.

Drug Mode of Action ::  

 Action Decreases blood glucose by stimulating insulin release from pancreas and by increasing tissue sensitivity to insulin.

Drug Interactions ::


Alcohol: Produces disulfiram-like reactions (facial flushing, headache, breathlessness). Androgens, chloramphenicol, clofibrate, fenfluramine, fluconazole, gemfibrozil, histamine H2 antagonists, magnesium salts, methyldopa, monoamine oxidase, oral anticoagulants, phenylbutazone, probenecid, salicylates, sulfinpyrazone, sulfonamides, tricyclic antidepressants, urinary acidifiers: Hypoglycemic effects may be increased. Betablockers, cholestyramine, diazoxide, hydantoins, rifampin, thiazide diuretics, urinary alkalinizers: May decrease hypoglycemic effect. Food: Absorption is delayed when taken with food. Give drug » 30 min before meal.

Drug Assesment ::


  • Obtain patient history, including drug history and any known allergies. Note hepatic or renal impairment and nature of patient’s diabetes (type I vs type II).
  • Check blood sugars frequently and observe for symptoms of hypoglycemia or hyperglycemia and report to health care provider.
  • Test urine for glucose and acetone at least three times daily during titration period; report results to health care provider.
  • When patients with impaired liver or renal function are receiving this drug, check liver and renal function tests frequently.
  Prolonged hypoglycemia, tingling of lips and tongue, hunger, nausea, lethargy, yawning, confusion, agitation, nervousness, tachycardia, sweating, tremor, convulsions, stupor, coma

Drug Storage/Management ::


  • Dose can be divided if single dose is not effective. Also divide doses if patient is taking > 15 mg/day.
  • Administer drug 30 min before meal; food delays absorption.
  • If administering to pregnant patient, discontinue at least 1 mo before expected date of delivery.
  • Store in tightly closed container at room temperature.

Drug Notes ::

 Patient/Family Education

  • Remind patient to take medication on empty stomach 30 min before meals.
  • Teach patient to self-monitor blood glucose.
  • Emphasize importance of following diabetic diet.
  • Inform patient that this drug is not substitute for exercise and diet control and that patient should follow prescribed regimens.
  • Instruct patient to inform all health care providers involved in his/her care that they are taking this drug.
  • Advise patient to carry identification stating that patient is diabetic.
  • Inform patient to contact his/her health care provider if symptoms of hypoglycemia occur (fatigue, excessive hunger, profuse sweating, numbness of extremities).
  • Tell patient to notify health care provider if symptoms of hyperglycemia occur (excessive thirst or urination, urinary glucose or ketones).
  • Instruct patient to report these symptoms to health care provider: Nausea, vomiting, diarrhea, heartburn, sore throat, rash, unusual bruising or bleeding or other physical complaints.
  • Advise patient not to take any medication (including otc) or alcohol without consulting health care provider.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.


One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.